Light beam targets stubborn lung tumors in new cancer trial
NCT ID NCT06943664
Summary
This study is testing whether combining a light-activated drug with immunotherapy can help control advanced non-small cell lung cancer that hasn't responded to standard treatments. The treatment involves injecting a drug that becomes active when exposed to a special laser light, which is aimed directly at tumors during a procedure. Researchers want to see if this combination approach can shrink tumors and extend survival for patients with limited treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.